Fitness

Orangetheory Is Training Every Coach on GLP-1s

Orangetheory is training all its coaches via a NASM GLP-1 course, marking a rare system-wide education shift driven by pharmacology, not programming.

A personal trainer instructs a member on a rowing machine in warm, natural studio lighting.

Orangetheory has quietly made a move that most gym brands haven't. The company is putting its entire coaching staff through a dedicated NASM course on GLP-1 medications, the class of weight-loss drugs that now includes household names like Ozempic, Wegovy, and Mounjaro. Every coach. Every studio. System-wide.

It's one of the first times a major boutique fitness brand has overhauled its coaching education in direct response to a pharmacological trend rather than a programming one. And it signals something the broader fitness industry has been slow to admit: GLP-1 users are not standard members, and training them like they are is a problem.

Why GLP-1 Users Need a Different Approach

GLP-1 receptor agonists work by suppressing appetite, slowing gastric emptying, and improving insulin sensitivity. The result is rapid weight loss. But that weight doesn't come from fat alone. Research consistently shows that people on GLP-1 medications lose a significant proportion of lean muscle mass alongside fat, often in the range of 25 to 40 percent of total weight lost, depending on the drug and dosage.

That's a serious problem if the goal is long-term health and body composition. Muscle loss accelerates metabolic slowdown, reduces functional strength, and increases the risk of what researchers call "sarcopenic obesity," where body fat returns but muscle doesn't. For a fitness brand whose core promise is transformation, ignoring this reality isn't just a missed opportunity. It's a liability.

GLP-1 users also arrive at class with significantly reduced caloric intake and, in many cases, lower energy availability. Training them at the same volume and intensity as a fully fueled member can increase injury risk and push them into overtraining before they or their coach even realizes it.

If you're on a GLP-1 and you've noticed you're hitting the wall earlier in class, that's not a fitness problem. It's a fueling and physiology problem that your coach now needs to understand.

What the NASM Course Actually Covers

NASM, one of the most widely recognized personal training certification bodies in the US, launched its GLP-1 coaching specialization to address exactly this gap. The course covers the mechanisms of GLP-1 drugs, how they affect body composition, energy systems, and exercise tolerance, and how coaches should adjust programming variables for members who are actively on them.

Key training adjustments the course addresses include:

  • Volume management: Reducing total work in a session when energy availability is low, without abandoning the training stimulus entirely.
  • Resistance training prioritization: Shifting emphasis toward muscle-preserving work, since cardio-dominant sessions do little to offset GLP-1-related muscle loss.
  • Protein cuing: Coaches learn when and how to prompt members about protein intake, since GLP-1 users often under-consume protein due to appetite suppression.
  • Intensity scaling: Recognizing when a member's reduced output signals a physiological response to the drug rather than a motivation issue.
  • Recovery awareness: Understanding that reduced caloric intake slows recovery timelines, which affects how frequently members can train at high intensities.

These aren't minor tweaks. They represent a fundamentally different coaching lens for a growing segment of the population that's showing up to class every week.

The Scale of the GLP-1 Shift in Fitness

The numbers justify the investment. As of 2024, an estimated 15 million Americans are using GLP-1 medications, with global prescriptions growing at a double-digit rate year over year. Goldman Sachs projects the GLP-1 market could reach $130 billion annually by 2030. That's not a niche trend. That's a structural shift in who walks through a gym door.

Boutique fitness brands, in particular, skew toward demographics that overlap heavily with GLP-1 users: women over 35, adults managing metabolic conditions, and higher-income members willing to invest in both a gym membership and prescription weight-loss treatment simultaneously. If you run a studio and you're not thinking about this yet, your membership data almost certainly suggests you should be.

The recent disruption in the compounded GLP-1 space adds another layer of complexity. As supply and regulatory dynamics shift, more members may be adjusting medications or switching formulations mid-program. For context on how that landscape is evolving, Hims and Hers Drops Compounded GLP-1s: What It Means breaks down the access and supply changes members may already be navigating.

The Muscle Loss Problem Is the Core Issue

It keeps coming back to muscle. GLP-1 drugs are extraordinarily effective at driving the scale down. They're not effective at ensuring the weight that leaves is fat rather than lean tissue. That gap is where fitness professionals have an enormous opportunity, and an obligation, to intervene.

Preserving muscle during rapid weight loss requires two things: sufficient protein intake and consistent resistance training stimulus. Both are harder to maintain on a GLP-1. Appetite suppression makes eating enough protein a genuine challenge, and reduced energy availability makes high-effort resistance training feel more demanding than usual.

This is especially relevant for members in their 40s, 50s, and beyond. The science on muscle preservation after midlife is unambiguous. Toned Arms After 50: What Science Actually Says covers how protein distribution and resistance training interact at the physiological level. The same principles apply with even more urgency when a GLP-1 is accelerating the conditions under which muscle can be lost.

For older members already managing age-related muscle decline, the stakes are higher still. Online Workouts Over 60: The Missing Ingredient addresses how sarcopenia risk compounds when nutrition and training aren't aligned. A coach who understands GLP-1 physiology is better equipped to flag when a member is heading in the wrong direction.

Programming Has to Evolve, Not Just Terminology

Understanding GLP-1 physiology changes how a thoughtful coach builds a session. It's not enough to tell a member to "listen to their body." Coaches need practical frameworks for adjusting volume and intensity in real time.

One area this affects directly is power and explosive work. High-intensity intervals and explosive movements carry a higher injury risk when a member is in a glycogen-depleted state from insufficient caloric intake. A coach who knows this can scale appropriately rather than pushing through. For context on how explosive work fits into a broader training plan under normal conditions, How to Add Explosive Work to Your Lifting Routine outlines the principles coaches should be weighing against GLP-1-related energy constraints.

Recovery between sessions also shifts. When caloric intake is suppressed, the physiological resources available for tissue repair are reduced. A member on a GLP-1 who trains five days a week at high intensity may be accumulating fatigue faster than their body can resolve it. Coaches now have a framework for identifying this pattern and recommending appropriate rest or reduced-intensity sessions without it seeming like a step backward.

What This Means for the Wider Fitness Industry

Orangetheory's move puts pressure on competitors. When a brand with over 1,500 locations worldwide rolls out system-wide pharmacological education for coaches, it raises the bar for what members should expect from any gym they walk into.

The personal training industry in the US generates over $12 billion annually. A substantial portion of clients seeking out coaches right now are either on GLP-1 medications or will be within the next two years. Coaches who can't speak to this, who can't adjust programming intelligently, who can't offer practical protein guidance for a client eating 1,200 calories a day, are going to lose ground to those who can.

This is also the beginning of a broader conversation about drug-aware fitness coaching. GLP-1s are the first medication class to reach a scale that makes universal coaching education necessary. They won't be the last. As pharmacological interventions become more embedded in everyday health management, the expectation that coaches understand drug-physiology interactions will only grow.

For now, Orangetheory has drawn the line in the sand. Every coach trained. Every member with access to someone who understands what's actually happening in their body. If you're on a GLP-1 and you've been training without that support, it's worth asking whether your gym is keeping up.